Retatrutide 20mg
Retatrutide is an experimental, once-weekly injectable medication designed to treat obesity and type 2 diabetes. Known as a “triple agonist,” it mimics three key metabolic hormones—GLP-1, GIP, and glucagon—to suppress appetite, regulate blood sugar, and boost the body’s baseline calorie and fat burn. In clinical trials, patients on the highest dose lost an average of…
Retatrutide is an experimental, once-weekly injectable medication designed to treat obesity and type 2 diabetes. Known as a “triple agonist,” it mimics three key metabolic hormones—GLP-1, GIP, and glucagon—to suppress appetite, regulate blood sugar, and boost the body’s baseline calorie and fat burn. In clinical trials, patients on the highest dose lost an average of about 24% of their body weight over 48 weeks with side effects primarily limited to mild-to-moderate gastrointestinal issues like nausea. It is currently in late-stage Phase 3 trials and is not yet approved for commercial use.
FOR RESEARCH USE ONLY
0 reviews for Retatrutide 20mg
There are no reviews yet. Only logged in customers who have purchased this product may leave a review. Log in


